Geroscience‐guided repurposing of FDA‐approved drugs to target aging: A proposed process and prioritization

Common chronic diseases represent the greatest driver of rising healthcare costs, as well as declining function, independence, and quality of life. Geroscience‐guided approaches seek to delay the onset and progression of multiple chronic conditions by targeting fundamental biological pathways of agi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, Ameya S., Aleksic, Sandra, Berger, David M., Sierra, Felipe, Kuchel, George A., Barzilai, Nir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009114/
https://www.ncbi.nlm.nih.gov/pubmed/35343051
http://dx.doi.org/10.1111/acel.13596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009114/
https://www.ncbi.nlm.nih.gov/pubmed/35343051
http://dx.doi.org/10.1111/acel.13596

Ejemplares similares